Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Janus Living, ordinary share
JAN, US4710241096

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Janus Living, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Included in the Free Plan
  • 100,000+ Stocks
  • 17,000+ ETFs
  • 150,000+ Mutual Funds

Start exploring global markets in less than 1 minute

  • Global Macro & Commodity Data
  • Research Hub & Basic Market News
  • AI Bond Screener
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product ...
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
  • Issuer
  • Full borrower / issuer name
    Janus Living, Inc.
  • Industry
    Real Estate Investment and Services

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NYSE
  • Ticker
    JAN
  • Placement
    20.03.2026
  • Lock up period
    180
  • Number of papers
    42,000,000
  • Volume of raised funds
    840 mln USD
  • Raised funds in USD
    -
  • Placement share
    23.21%
  • Final placement price
    20 USD
  • Price change since placement date
    50.25%
  • By capitalization
    3,618.46 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NYSE
  • Ticker
    JAN
  • Placement
    11.08.2026
  • Lock up period
    180
  • Number of papers
    16,000,000
  • Volume of raised funds
    464 mln USD
  • Raised funds in USD
    -
  • Placement share
    6.9%
  • Final placement price
    29 USD
  • Price change since placement date
    3.62%
  • By capitalization
    6,727.22 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NYSE
  • Ticker
    JAN
  • Placement
    03.06.2026
  • Lock up period
    180
  • Number of papers
    25,000,000
  • Volume of raised funds
    625 mln USD
  • Raised funds in USD
    -
  • Placement share
    11.78%
  • Final placement price
    25 USD
  • Price change since placement date
    20.2%
  • By capitalization
    5,305.57 mln USD

Indicators

IFRS/US GAAP reports

Holders

Industry Leaders

Registration is required to get access.